Superior Biologics: Funding, Investors & Team (Sep 2026)
Superior Biologics is a leading provider of intravenous and injectable medications for patients with chronic disorders. Our mission is to provide cost effective, patient specific services, which offer patients the freedom to lead normal lives and have optimal therapeutic outcomes. We are dedicated to understanding the changing demands of caring for patients with chronic disorders. We respond to the individual needs of patients and their families by providing personal service backed by highly qualified professionals. Superior Biologics is based in Hawthorne, New York (Westchester County), and primarily services the tri-state area of New York, New Jersey and Connecticut. Based on our pharmacy licensure, we are also able to service patients in various other states in addition to this immediate geographic area. Please contact us to find out if we are able to service your area.
Superior Biologics has raised $136M across 1 funding round on record, the most recent an undisclosed round of $136M announced in Dec 2022.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Superior Biologics Company Profile and Key Stats
Latest funding round on record: Dec 2022.
Superior Biologics Funding Rounds
Superior Biologics Founders and Leadership Team
No contact details are on record for this team yet.
Superior Biologics Funding Compared to Other Biotechnology Startups
Superior Biologics' latest round of $136M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Superior Biologics in Biotechnology and Hawthorne
Companies Similar to Superior Biologics
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Superior Biologics Funding FAQs
What does Superior Biologics do?
Superior Biologics is a leading provider of intravenous and injectable medications for patients with chronic disorders. Our mission is to provide cost effective, patient specific services, which offer patients the freedom to lead normal lives and have optimal therapeutic outcomes. We are dedicated to understanding the changing demands of caring for patients with chronic disorders. We respond to the individual needs of patients and their families by providing personal service backed by highly qualified professionals. Superior Biologics is based in Hawthorne, New York (Westchester County), and primarily services the tri-state area of New York, New Jersey and Connecticut. Based on our pharmacy licensure, we are also able to service patients in various other states in addition to this immediate geographic area. Please contact us to find out if we are able to service your area.
How much funding has Superior Biologics raised?
Superior Biologics has raised $136M across 1 round on record. The most recent is an undisclosed round of $136M announced in Dec 2022.
When did Superior Biologics last raise funding?
Superior Biologics' most recent funding round on record is an undisclosed round of $136M, announced in Dec 2022.
Who is the CEO of Superior Biologics?
Mark Kovinsky is listed as CEO at Superior Biologics.
Where is Superior Biologics headquartered?
Superior Biologics is based in Hawthorne, New York, United States.
How many employees does Superior Biologics have?
Superior Biologics is in the 51-100 employee band.
How does Superior Biologics' funding compare to other Biotechnology startups?
Superior Biologics' latest round of $136M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Superior Biologics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Superior Biologics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.